SCHULER JACK W
Known title: DirectorCIK: 0001021412
SCHULER JACK W's purchase track record
How the stock did after each of SCHULER JACK W's open-market purchases, measured from the purchase date. Several fills within a week count as one purchase.
Purchases measured
16
of 17 since August 19, 2021
Stock higher 6 months later
38%
3 months: 38%
Median 6-month return
-12.0%
3 months: -6.7%
Beat the S&P 500
38%
median -16.7% vs. index
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 8/10/2026 | BDSX | $1.03M | pending | pending | — |
| 1/22/2026 | BDSX | $2.08M | -10.3% | +101.1% | +7.2% |
| 9/17/2025 | BDSX | $1.11M | +21.4% | +159.1% | +0.4% |
| 8/29/2025 | BDSX | $1.50M | -3.0% | +79.5% | +6.5% |
| 5/16/2025 | BDSX | $1.32M | +31.6% | +32.9% | +13.0% |
| 11/20/2024 | BDSX | $357K | -20.6% | -66.8% | -1.2% |
| 11/5/2024 | BDSX | $137K | -25.4% | -66.6% | -3.0% |
| 8/21/2023 | BDSX | $217K | -14.5% | -10.2% | +13.1% |
| 5/30/2023 | BDSX | $36K | +14.9% | +6.4% | +8.3% |
| 5/22/2023 | BDSX | $213K | +48.2% | +26.8% | +8.5% |
| 1/27/2023 | BDSX | $150K | -30.8% | -57.2% | +12.6% |
| 12/12/2022 | BDSX | $618K | +8.6% | -4.6% | +8.7% |
| 11/21/2022 | BDSX | $10.00M | +76.9% | -13.9% | +6.1% |
| 4/7/2022 | BDSX | $5.00M | 0.0% | -16.2% | -16.8% |
| 12/30/2021 | BDSX | $10.00M | -61.7% | -62.8% | -20.8% |
| 11/17/2021 | BDSX | $827K | -47.5% | -75.6% | -16.3% |
| 8/19/2021 | BDSX | $384K | -19.1% | -58.7% | -0.6% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| BDSX | ▲ Buy | Open Market | 15,000 | $367K | 8/12/2026 | View on chart |
| BDSX | ▲ Buy | Open Market | 13,700 | $329K | 8/11/2026 | View on chart |
| BDSX | ▲ Buy | Open Market | 13,900 | $337K | 8/10/2026 | View on chart |
| BDSX | ▲ Buy | Open Market | 20,000 | $236K | 1/26/2026 | View on chart |
| BDSX | ▲ Buy | Open Market | 80,000 | $945K | 1/23/2026 | View on chart |
| BDSX | ▲ Buy | Open Market | 82,465 | $904K | 1/22/2026 | View on chart |
| BDSX | ▲ Buy | Open Market | 142,045 | $1000K | 9/19/2025 | View on chart |
| BDSX | ▲ Buy | Open Market | 3,056 | $19K | 9/18/2025 | View on chart |
| BDSX | ▲ Buy | Open Market | 15,317 | $93K | 9/17/2025 | View on chart |
| BDSX | ▲ Buy | Open Market | 3,488,372 | $1.5M | 8/29/2025 | View on chart |
| BDSX | ▲ Buy | Open Market | 723,239 | $247K | 5/19/2025 | View on chart |
| BDSX | ▲ Buy | Open Market | 4,000,000 | $1.1M | 5/16/2025 | View on chart |
| BDSX | ▲ Buy | Open Market | 100,000 | $123K | 11/21/2024 | View on chart |
| BDSX | ▲ Buy | Open Market | 200,000 | $234K | 11/20/2024 | View on chart |
| BDSX | ▲ Buy | Open Market | 100,253 | $137K | 11/5/2024 | View on chart |
| BDSX | ▲ Buy | Option Exercise | 86,960 | — | 5/23/2024 | View on chart |
| BDSX | ▲ Buy | Open Market | 87,500 | $149K | 8/23/2023 | View on chart |
| BDSX | ▲ Buy | Open Market | 8,307 | $14K | 8/22/2023 | View on chart |
| BDSX | ▲ Buy | Open Market | 32,556 | $53K | 8/21/2023 | View on chart |
| BDSX | ▲ Buy | Grant | 9,989,506 | $16.2M | 8/3/2023 | View on chart |
| BDSX | ▲ Buy | Open Market | 14,792 | $20K | 5/31/2023 | View on chart |
| BDSX | ▲ Buy | Open Market | 11,849 | $16K | 5/30/2023 | View on chart |
| BDSX | ▲ Buy | Open Market | 52,508 | $71K | 5/25/2023 | View on chart |
| BDSX | ▲ Buy | Open Market | 35,308 | $44K | 5/24/2023 | View on chart |
| BDSX | ▲ Buy | Open Market | 56,782 | $65K | 5/23/2023 | View on chart |
| BDSX | ▲ Buy | Open Market | 29,425 | $33K | 5/22/2023 | View on chart |
| BDSX | ▲ Buy | Open Market | 10,000 | $24K | 1/31/2023 | View on chart |
| BDSX | ▲ Buy | Open Market | 50,000 | $125K | 1/27/2023 | View on chart |
| BDSX | ▲ Buy | Open Market | 10,000 | $17K | 12/16/2022 | View on chart |
| BDSX | ▲ Buy | Open Market | 20,000 | $33K | 12/15/2022 | View on chart |
| BDSX | ▲ Buy | Open Market | 189,675 | $313K | 12/14/2022 | View on chart |
| BDSX | ▲ Buy | Open Market | 67,402 | $107K | 12/13/2022 | View on chart |
| BDSX | ▲ Buy | Open Market | 100,000 | $148K | 12/12/2022 | View on chart |
| BDSX | ▲ Buy | Open Market | 8,695,652 | $10.0M | 11/21/2022 | View on chart |
| BDSX | ▲ Buy | Open Market | 2,793,296 | $5.0M | 4/7/2022 | View on chart |
| BDSX | ▲ Buy | Open Market | 2,298,850 | $10.0M | 12/30/2021 | View on chart |
| BDSX | ▲ Buy | Open Market | 20,000 | $127K | 11/22/2021 | View on chart |
| BDSX | ▲ Buy | Open Market | 60,000 | $390K | 11/19/2021 | View on chart |
| BDSX | ▲ Buy | Open Market | 28,361 | $180K | 11/18/2021 | View on chart |
| BDSX | ▲ Buy | Open Market | 20,000 | $130K | 11/17/2021 | View on chart |
| BDSX | ▲ Buy | Open Market | 50,000 | $384K | 8/19/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 27, 2026
Biodesix Expands MRD Monitoring Through New Partnerships
Biodesix announced progress in two collaborative programs aimed at tumor‑informed and tumor‑naïve molecular residual disease (MRD) solutions. The company also advanced its MRD monitoring programs by partnering with Bio‑Rad and Thermo Fisher. These developments broaden Biodesix’s portfolio of diagnostic tools for cancer patients.
Biodesix Expands MRD Monitoring Through New Partnerships. Biodesix announced progress in two collaborative programs aimed at tumor‑informed and tumor‑naïve molecular residual disease (MRD) solutions. The company also advanced its MRD monitoring programs by partnering with Bio‑Rad and Thermo Fisher. These developments broaden Biodesix’s portfolio of diagnostic tools for cancer patients.